tiprankstipranks
Trending News
More News >
Hisamitsu Pharmaceutical Co (JP:4530)
:4530
Advertisement

Hisamitsu Pharmaceutical Co

Compare
1 Followers

4530 Stock Chart & Stats

¥4020.00
-¥16.00(-0.39%)
At close: 4:00 PM EST
¥4020.00
-¥16.00(-0.39%)

Hisamitsu Pharmaceutical Co News

4530 FAQ

What was Hisamitsu Pharmaceutical Co’s price range in the past 12 months?
Hisamitsu Pharmaceutical Co lowest stock price was ¥3783.00 and its highest was ¥4735.00 in the past 12 months.
    What is Hisamitsu Pharmaceutical Co’s market cap?
    Hisamitsu Pharmaceutical Co’s market cap is ¥286.82B.
      When is Hisamitsu Pharmaceutical Co’s upcoming earnings report date?
      Hisamitsu Pharmaceutical Co’s upcoming earnings report date is Jan 08, 2026 which is in 69 days.
        How were Hisamitsu Pharmaceutical Co’s earnings last quarter?
        Hisamitsu Pharmaceutical Co released its earnings results on Jan 09, 2025. The company reported ¥62.31 earnings per share for the quarter, beating the consensus estimate of N/A by ¥62.31.
          Is Hisamitsu Pharmaceutical Co overvalued?
          According to Wall Street analysts Hisamitsu Pharmaceutical Co’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Hisamitsu Pharmaceutical Co pay dividends?
            Hisamitsu Pharmaceutical Co pays a Notavailable dividend of ¥60 which represents an annual dividend yield of 2.6%. See more information on Hisamitsu Pharmaceutical Co dividends here
              What is Hisamitsu Pharmaceutical Co’s EPS estimate?
              Hisamitsu Pharmaceutical Co’s EPS estimate is 137.1.
                How many shares outstanding does Hisamitsu Pharmaceutical Co have?
                Hisamitsu Pharmaceutical Co has 75,164,894 shares outstanding.
                  What happened to Hisamitsu Pharmaceutical Co’s price movement after its last earnings report?
                  Hisamitsu Pharmaceutical Co reported an EPS of ¥62.31 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.173%.
                    Which hedge fund is a major shareholder of Hisamitsu Pharmaceutical Co?
                    Currently, no hedge funds are holding shares in JP:4530

                    Company Description

                    Hisamitsu Pharmaceutical Co

                    Hisamitsu Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company primarily engaged in the development, manufacturing, and marketing of pharmaceutical products. Known for its focus on transdermal drug delivery systems, the company is a leader in the production of medicated patches and topical treatments. Its core products include the Salonpas line of pain relief patches, which are widely recognized and distributed globally, as well as a range of prescription medications and over-the-counter products. Hisamitsu operates primarily within the healthcare and pharmaceutical sectors, with a strong emphasis on research and innovation in drug delivery technologies.

                    Hisamitsu Pharmaceutical Co (4530) Earnings & Revenues

                    4530 Stock 12 Month Forecast

                    Average Price Target

                    ¥4,299.88
                    ▲(6.96% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3791":"¥3,791","3936":"¥3,936","4081":"¥4,081","4226":"¥4,226","4371":"¥4,371"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":4299.8779744687,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">¥4.30K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4299.8779744687,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">¥4.30K</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4299.8779744687,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">¥4.30K</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3791,3936,4081,4226,4371],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jun<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4079,4095.9906134206694,4112.981226841339,4129.971840262007,4146.962453682677,4163.953067103346,4180.943680524016,4197.934293944684,4214.924907365354,4231.915520786023,4248.9061342066925,4265.896747627361,4282.8873610480305,{"y":4299.8779744687,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4079,4095.9906134206694,4112.981226841339,4129.971840262007,4146.962453682677,4163.953067103346,4180.943680524016,4197.934293944684,4214.924907365354,4231.915520786023,4248.9061342066925,4265.896747627361,4282.8873610480305,{"y":4299.8779744687,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,4079,4095.9906134206694,4112.981226841339,4129.971840262007,4146.962453682677,4163.953067103346,4180.943680524016,4197.934293944684,4214.924907365354,4231.915520786023,4248.9061342066925,4265.896747627361,4282.8873610480305,{"y":4299.8779744687,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3792.004,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":4370.512,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":4130.524,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":3985.165,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":4346.123,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":4163.943,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":4099.867,"date":1743465600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":4286.18,"date":1746057600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":4286.18,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4032.834,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4045.649,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4290,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4079,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Sumitomo Dainippon Pharma Co
                    Torii Pharmaceutical Co
                    Tsumura & Co
                    Nippon Shinyaku Co., Ltd.
                    SAWAI GROUP HOLDINGS Co., Ltd.

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis